ACET Q2 2020 Earnings — Adicet Bio, Inc. Revenue & Financial Results | Market Cap Arena

ACETAdicet Bio, Inc.

$71M

Q2 2020 Earnings

Healthcare Biotechnology

Income Statement

Revenue

$7M+125.9% YoY

Gross Profit

$7M100.0% margin

Operating Income

-$9M-115.6% margin

Net Income

-$8M-113.3% margin

EPS (Diluted)

$-7.36

QoQ Revenue Growth

+273.3%

Cash Flow

Operating Cash Flow

-$12M

Free Cash Flow

-$12M

Stock-Based Comp.

$351,000

Balance Sheet

Total Assets

$74M

Total Liabilities

$4M

Stockholders' Equity

$71M

Cash & Equivalents

$71M

Year-over-Year Comparison

Metric	Current	Year Ago	Change
Revenue	$7M	$3M	+125.9%
Gross Profit	$7M	$3M	+125.9%
Operating Income	-$9M	-$5M	-87.0%
Net Income	-$8M	-$3M	-218.9%